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The development of renal ischemia has been postulated to
be a main cause of the progressive nature of kidney diseases.
In recent years, it has become clear that inappropriate and
sustained activation of the endothelium could mediate this
phenomenon. Endothelial activation will result in leucostasis
and can compromise peritubular flow. The associated
sustained redox signaling will also accelerate the
development of endothelial senescence. In addition, risk
factors for renal disease progression can reduce endothelial
repair. In the course of these events, loss of capillary structure
and rarefaction develops, which drives the further
development of nephron loss. In this mini review, the
evidence for this pathophysiological concept as well as the
possibility to detect such endothelial activation in the clinical
arena is summarized.
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In recent years, we have come to understand that the
progressive nature of many renal diseases in a way is a
remarkable phenomenon as the kidney is capable of
substantial repair. These repair processes are not limited to
the tubular epithelium but also include complex structures
such as glomeruli. For example, in the anti-Thy1 glomerulo-
nephritis model, glomerular capillaries, mesangium, and
podocytes are all being regenerated.1 Also in human renal
disease such as type I diabetes and anti-neutrophil cytoplas-
mic antibody associated glomerulonephritis, glomerular
regeneration could be observed.2,3 This implies that in
progressive renal disease, the natural recovery processes of
the kidney somehow must have become compromised. In
this mini review, we discuss the hypothesis that recurrent
endothelial activation and loss of renal endothelial repair
could be the Achilles heel in this natural recovery potential of
the kidney. In particular, activation of the peritubular
endothelium in the renal medulla may compromise renal
perfusion and result in loss of tubular function.
ENDOTHELIAL CELL ACTIVATION AND RENAL PERFUSION
The close and countercurrent apposition of the medullar
peritubular plexus in descending and ascending vasa recta
allows oxygen and nutrient diffusion to be shunted back to
the cortex.4 Clearly, this is the basis for maintenance of a
corticomedullary osmotic gradient and regulation of water
transport, but it also renders the medulla relatively hypoxic
(10–15 mm Hg). This phenomenon in combination with
oxygen consumption by tubular epithelium, in particular the
medullary thick ascending limb (mTAL), sensitizes the renal
(outer) medullary epithelium to ischemia. Epithelial survival
in such an environment thus depends upon an intricate
interplay between the peritubular endothelium, interstitial
cells and the tubular cell itself. Although these cells are
equipped with adaptive mechanisms to function in this
milieu (see below), the hypoxic environment reduces
the margin for survival. Experimental data have shown
that hypoxia may drive renal fibrosis as well, by
inducing epithelial-mesenchymal transformation and fibroblast
activation.5
In general, tubular epithelium can tolerate hypoxia
relatively well. Induction of a hypoxia-inducible factor-1
(HIF-1) response is probably a central mechanism. Tubular
m i n i r e v i e w http://www.kidney-international.org
& 2007 International Society of Nephrology
Received 8 May 2007; accepted 29 May 2007; published online 4 July
2007
Correspondence: TJ Rabelink, Department of Nephrology, Einthoven Centre
of Experimental Vascular Medicine and Diabetes, Leiden University Medical
Center, PO Box 9600, Leiden 2300 RC, The Netherlands.
E-mail: t.rabelink@lumc.nl
926 Kidney International (2007) 72, 926–930
epithelium also has a very strong potential to regenerate. Per
hour about 70 000 tubular epithelial cells are shed in the
urine and replaced.6 Complete resolution of massive tubular
cell necrosis in clinical acute renal failure can be observed.
This high capacity for tubular repair is thought to primarily
reflect the intrinsic capacity of surviving epithelial cells to
dedifferentiate and proliferate. More recently, the renal
papilla has been recognized as a stem cell niche and it has
been proposed that these cells may play a role in repair as
well.7 Although in older age, signs of tubular senescence can
be noticed,8 there is little clinical or experimental evidence of
failure of tubular regenerative potential in the presence of
adequate perfusion.
By contrast, there is considerable evidence that the
capillary perfusion and integrity of the renal endothelium
is a locus minoris resistentiae. One of the key characteristics
of the endothelial cell (EC) is their ability to respond to
metabolic and immunological signals. This is normal
endothelial physiology as it allows leukocytes to target to
sites of infection and to adapt tissue perfusion. The EC does
so by switching from the quiescent NO signaling dominated
phenotype, to redox signaling resulting in endothelial
activation.9 In many renal diseases, this (physiological)
endothelial redox signaling is inappropriately activated by
factors such as angiotensin II, modified (lipo)proteins,
insulin resistance, and elevated uric acid. Sustained endothe-
lial activation may impact on the renal microcirculation.
Rolling and sticking of leukocytes will reduce blood flow in
the capillaries. As in the kidney, oxygen consumption directly
depends on blood flow, it is likely that such endothelium–-
leukocyte interactions will thus reduce oxygen tensions
(Figure 1).10 Although renal ECs themselves express HIF-
2a, which induces strong prosurvival responses to hypoxia,
such reductions in renal tissue oxygenation may jeopardize
tubular survival. Secondly, sustained production of reactive
oxygen species will exceed the capacity of the endothelial
enzymatic and non-enzymatic anti-oxidants and results in
protein modifications and stress-induced senescence. Activa-
tion of the tumor suppressor P53 and subsequent lysosomal
destabilization is probably a main mechanism driving the
development of senescence.11 Careful labeling studies with
proliferation markers such as Ki67 have demonstrated, even
in healthy subjects, the presence of a very high glomerular
and peritubular EC turnover. The proliferation index doubles
that of the tubular epithelial cells.6 This likely is a reflection
of ongoing microvascular repair. This high cell turnover may
have further implications for regenerative capacity of the
ECs. DNA synthesis during cell division results in the
progressive shortening of telomeric DNA and replicative
senescence, in particular, in the presence of low activity of the
telomere synthesizing enzyme telomerase. The importance of
loss of telomerase activity for endothelial repair is illustrated
by experiments where forced expression of the catalytic unit
of telomerase, Telomerase Reverse Transcriptase (TERT) can
expand endothelial lifespan and its proliferative capacity.12
Redox stress has been identified as the main cause of loss of
telomerase activity13 adding another mechanism that reduces
endothelial renewal upon its activation. With the develop-
ment of endothelial senescence in the kidney, capillary
attrition will develop as well resulting in nephron drop-out
(see below).
ENDOTHELIAL BACK-UP SYSTEMS
In recent years, attention has been drawn to circulating
progenitor cells, as well as to resident mural cells that can
participate in re-endothelialization and could act as a salvage
mechanism to restore the renal microcirculation. In the
capillary circulation, it appears to be primarily the circulating












Figure 1 | Working hypothesis on the role of peritubular capillary function as a determinant of renal function. Endothelial activation
in the microcirculation allows rolling and stickiness of leukocyte thus reducing peritubular perfusion in the peritubular capillaries and oxygen
and nutrient delivery to the tubular epithelium. Sustained endothelial activation will finally lead to EC detachment. Local endothelial
and tubular cells can regenerate and restore endothelial capillary integrity. When senescence of resident ECs occurs the capillary architecture
may become dependent upon re-endothelialization by resident or circulating progenitor populations that can differentiate into endothelial-like
cells under the influence of hypoxia inducible cytokines such as VEGF and erythropoietin. Maintenance of the peritubular network and thus
epithelial function is then determined by the balance between endothelial injury and repair. When these back-up systems fail thrombotic
occlusion occurs and nephron drop-out develops.
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populations that can contribute to re-endothelialization,
whereas in larger vessels, resident progenitors are probably
more important.14 This is exemplified by studies in human
kidney and bone marrow transplantation patients where
(bone marrow) derived circulating cells were found to have
incorporated in peritubular capillaries.15 The origin and
functional importance of this repair mechanism is still under
debate. In vitro studies have mostly focused on the
endothelial differentiation of a hemangioblast-like bone
marrow progenitor cell.16 These are, however, rare cells and
their clinical repair potential is relatively unexplored. The
in vivo evidence of progenitor-mediated repair is mostly
based on attaching mononuclear cells that have committed to
an endothelial-like phenotype as illustrated by expression of,
for example, von Willebrand factor and endothelial nitric
oxide synthase. These cells are present in large numbers in the
circulation. Infusion of these cells has been shown to restore
damaged endothelial surface and stimulate angiogenesis.17 At
close examination, these cells bear characteristics of myeloid
cells with the potential to become immune competent cells as
well when exposed to an inflammatory milieu.18 Never-
theless, in the model of adriamycin glomerulonephritis in the
mouse, integrity of the capillaries was shown to depend upon
recruitment of bone marrow-derived progenitor cells. By
preventing apoptosis of these progenitor cells, the investiga-
tors could not only preserve the capillary structures, but also
prevent the development of tubular atrophy.19
It may well be that interstitial cells also provide signals for
maintenance of the peritubular capillary network, particu-
larly during decrements in oxygen delivery. Interstitial cells
have been shown to be a main source of HIF-2-mediated
transcriptional defense against hypoxia. These include the
production of the cytoprotective erythropoietin, progenitor
cell recruiting cytokines such as vascular endothelial growth
factor (VEGF) and stromal cell-derived factor 1 (SDF-1), and
modulation of the extracellular matrix.20
Finally, one can hypothesize that the tubular epithelium
itself may play a role in maintaining peritubular endothe-
lium. In recent years, it has become clear that vascular
structures require continuous exposure to growth factors
such as VEGF and angiopoietin I not to disintegrate. Seminal
work of the Quaggin group has shown that at the glomerular
level, VEGF release from epithelial cells is essential for
maintenance and survival of the glomerular endothelium.21
Also the tubular epithelium has been recognized as a site of
VEGF production, whereas overexpression of HIF-1 in
tubular cells could promote proliferation of ECs.22
PERITUBULAR RAREFACTION: CAUSE OR EFFECT?
Many clinical biopsy studies have shown an association
between loss of tubular function and structure on the one
hand and loss of glomerular and peritubular endothelium on
the other. These conditions vary from glomerulonephritis, to
diabetes as well as to loss of allograft function.5,23–25
Experimental studies, which allow sequential follow-up,
revealed that the loss of proximal tubular cell (PTC)
(rarefaction) in fact precedes the development of tubulo-
interstitial fibrosis. Micro fill analysis in rats subjected to
bilateral ischemia followed by reperfusion revealed a 30–50%
reduction in PTC density as early as 4–8 weeks, whereas
tubulointerstitial fibrosis and proteinuria started to develop
at 16 weeks.26 Similar observations were carried out in a rat
model with aristolochic acid nephropathy, where there was a
progressive reduction in PTCs from the 8th week onwards,
whereas tubular atrophy developed from week 16 onwards.25
In a model of accelerated glomerulosclerosis using repeated
anti-Thy1 injections, stagnation of peritubular capillary flow
was observed, preceding the development of tubulointerstitial
injury and loss of peritubular capillaries.27 Finally, in animal
models with nephrosis, any histological evidence of tubulo-
interstitial fibrosis was antedated by hypoxia (confirmed by a
dramatic and significant increase in nuclear localization of
HIF-1a) following loss of PTCs and decreased PTC blood
flow.5,24,25
A direct causal relationship between endothelial injury
and the development of tubulointerstitial disease is further
supported by studies that have specifically modulated
endothelial function. For example, endothelial overexpres-
sion of the receptor for advanced glycation end products
(RAGE) induces proteinuria and progressive kidney disease.28
Endothelial activation may start at the glomerular level with
endothelial–leukocyte interaction and development of fibrin
and platelet thrombi and subsequently may also compromise
efferent flow to the peritubular capillaries. Such changes at
the glomerular endothelium could, for example, be observed
when diabetes was induced in the absence of a functional
endothelial NOS.29 Conversely, restoration of endothelial
function prevents the development of tubular atrophy. For
example, EC infusion in ischemia-reperfusion injury of the
kidney has been shown to restore areas where ECs have
detached and reduced tubular injury.30 The importance for
maintenance of endothelial integrity is further illustrated by
the aforementioned study by Li et al.19 where reduction of
apoptosis of progenitor-derived peritubular EC could reduce
the development of tubulointerstitial disease.
CAN WE CLINICALLY ASSESS RENAL ENDOTHELIAL
ACTIVATION?
Obviously, the kidney itself is not easy to access and to assess
the presence of endothelial activation or its anatomical
consequence rarefaction. However, there is substantial
evidence that EC activation is a systemic process that occurs
in a similar manner in multiple tissue beds throughout the
body. Endothelial function is most frequently measured by its
capacity to induce vasodilatation in response to specific
agonists or increased shear stress.31 Brachial flow-mediated
vasodilatation is most widely used and has also been studied
in patients with renal disease.32 Unfortunately, this metho-
dology has thus far not been used to predict progression
of renal disease. In experimental conditions, however, endo-
thelium-dependent vasodilatation of renal arteries was a very
strong predictor of development of injury and proteinuria in
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models of 5/6 nephrectomy and adriamycin nephrosis,33 thus
providing a rationale for such studies.
More relevant to the process of endothelial activation in
the kidney probably would be to assess the interaction of the
endothelium with leukocytes. Recently, it was shown that
orthogonal polarization spectroscopy of the sublingual
circulation can be used to measure endothelial glycocalyx
thickness and leukocyte–endothelial interaction.34 In a pilot
study, it was suggested that microalbuminuria could be
related to decrements in glycocalix. Such intravital micro-
scopic techniques also allow direct visualization of the
microvasculature and measurements of capillary density.
Although associations between peripheral capillary density
and the occurrence of diabetic retinopathy have been found,
no such relationships have been explored with respect to the
potential to predict of renal disease progression.
As acquired rarefaction can be considered failure of
endothelial repair mechanisms, one may also consider
enumerating circulating progenitor cells as a proxy of
regenerative capacity. Indeed, in the field of cardiology,
measuring circulating CD34/kdr-positive cells has been
shown to predict the occurrence of cardiovascular events.35
As discussed before, the clinical relevance of these cells for
repair is still uncertain and the fact that they predict
cardiovascular events may well be related to the fact that
release from the bone marrow is a NO-dependent process.36
Characterization of myeloid precursor cells for surface
markers that indicate endothelial commitment is clinically
feasible and could be investigated as an alternative approach
to assess repair capacity.
CONCLUSION
The recent appreciation of the potential to repair damaged
renal tissue also changes our working hypothesis on the
progressive nature of renal disease. Loss of renal function can
thus be considered as a dysbalance between injury and repair.
Whereas the capacity of epithelial regeneration has long been
recognized, and more recently even extended to glomerular
epithelium, we propose that renal endothelium may be more
limited in its repair capacity. This drives a vicious circle of
rarefaction and renal ischemia leading to loss of nephrons. It
would implicate that repair and maintenance of the
peritubular capillaries could be a therapeutic target for
prevention of loss of renal function.
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